These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 23421499)
1. Humoral autoimmune response to IGF2 mRNA-binding protein (IMP2/p62) and its tissue-specific expression in colon cancer. Liu W; Li Z; Xu W; Wang Q; Yang S Scand J Immunol; 2013 Apr; 77(4):255-60. PubMed ID: 23421499 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer. Liu W; Li Y; Wang B; Dai L; Qian W; Zhang JY Scand J Immunol; 2015 Jun; 81(6):502-7. PubMed ID: 25721883 [TBL] [Abstract][Full Text] [Related]
3. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. Liu X; Ye H; Li L; Li W; Zhang Y; Zhang JY J Immunol Res; 2014; 2014():326593. PubMed ID: 24872956 [TBL] [Abstract][Full Text] [Related]
4. The diversity expression of p62 in digestive system cancers. Su Y; Qian H; Zhang J; Wang S; Shi P; Peng X Clin Immunol; 2005 Aug; 116(2):118-23. PubMed ID: 15886058 [TBL] [Abstract][Full Text] [Related]
5. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Li Y; Francia G; Zhang JY Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related]
7. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C]. Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773 [TBL] [Abstract][Full Text] [Related]
8. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. Kessler SM; Pokorny J; Zimmer V; Laggai S; Lammert F; Bohle RM; Kiemer AK Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G328-36. PubMed ID: 23257922 [TBL] [Abstract][Full Text] [Related]
9. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Ersvaer E; Bertelsen LT; Espenes LC; Bredholt T; Bøe SO; Iversen BM; Bruserud Ø; Ulvestad E; Gjertsen BT Scand J Immunol; 2004; 60(1-2):189-98. PubMed ID: 15238089 [TBL] [Abstract][Full Text] [Related]
10. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350 [TBL] [Abstract][Full Text] [Related]
11. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer. Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of IGF2 mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival. Barghash A; Helms V; Kessler SM Scand J Immunol; 2015 Aug; 82(2):142-3. PubMed ID: 25916626 [No Abstract] [Full Text] [Related]
13. Profiling tumor-associated autoantibodies for the detection of colon cancer. Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234 [TBL] [Abstract][Full Text] [Related]
14. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341 [TBL] [Abstract][Full Text] [Related]
15. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Mahler M; Silverman ED; Fritzler MJ Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China. Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609 [TBL] [Abstract][Full Text] [Related]
17. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. Wu CH; Xu XY; Tian GS; Yu YY Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548 [TBL] [Abstract][Full Text] [Related]
18. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361 [TBL] [Abstract][Full Text] [Related]
19. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339 [TBL] [Abstract][Full Text] [Related]
20. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]